283 related articles for article (PubMed ID: 17229605)
1. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
3. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
[TBL] [Abstract][Full Text] [Related]
4. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
Leynadier F; Duarte-Risselin C; Murrieta M
Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819
[TBL] [Abstract][Full Text] [Related]
5. Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus terfenadine in the treatment of seasonal allergic rhinitis.
Corrado ME; Radicioni MM; Hartwig J; Assandri A; Oldeman HG; Mion A
Arzneimittelforschung; 2004; 54(10):660-5. PubMed ID: 15553105
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis.
Horak F; Stübner P; Zieglmayer R; Kavina A; Corrado ME; Assandri A; Mion A
Arzneimittelforschung; 2004; 54(10):666-72. PubMed ID: 15553106
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.
Monroe EW; Bernstein DI; Fox RW; Grabiec SV; Honsinger RW; Kalivas JT; Katz HI; Cuss F; Danzig MR; Garvin PR
Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478
[TBL] [Abstract][Full Text] [Related]
9. [Results of treatment with loratadine in patients with chronic urticaria].
Siergiejko Z; Chyrek-Borowska S
Pol Tyg Lek; 1994 Apr 4-11; 49(14-15):334-6. PubMed ID: 7854994
[TBL] [Abstract][Full Text] [Related]
10. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
Wang RQ; Zhang HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
[TBL] [Abstract][Full Text] [Related]
12. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
Monroe EW
Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
[TBL] [Abstract][Full Text] [Related]
13. Controlled clinical study of the efficacy of loratadine in Nigerian patients with allergic rhinitis.
Nwawolo CC; Olusesi AD
Niger Postgrad Med J; 2001 Sep; 8(3):127-32. PubMed ID: 11721215
[TBL] [Abstract][Full Text] [Related]
14. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D
Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
[TBL] [Abstract][Full Text] [Related]
17. Prevention of recurrent wheezing in young children by loratadine compared with ketotifen.
Ngamphaiboon J; Wirawarn T; Thongkaew T
J Med Assoc Thai; 2009 Mar; 92(3):351-5. PubMed ID: 19301727
[TBL] [Abstract][Full Text] [Related]
18. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
Sussman G; Jancelewicz Z
Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
[TBL] [Abstract][Full Text] [Related]
19. Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.
Murota H; Katayama I
Expert Opin Pharmacother; 2009 Aug; 10(11):1859-67. PubMed ID: 19558341
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model.
Abelson MB; Kaplan AP
Clin Ther; 2002 Mar; 24(3):445-56. PubMed ID: 11952027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
